In their assessment, FDA scientists said that patients who received MDMA and talk therapy showed ‘rapid, clinically meaningful, durable improvements in their PTSD symptoms.’
People who want to use the service come in and give a sample of their drugs to staff. They put it in a machine that can usually show the main components of the drug and the potential risks in minutes.
It’s part of a long-term trend toward studying whether doing less—less surgery, less chemotherapy or less radiation—can help patients live longer and feel better.
